Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kayleigh Gray
Institution:
Berg (United States)
Observed institutions:
Western General Hospital,
Berg (United States)
ORCID:
0000-0002-4329-4040
Observed ORCID:
0000-0002-4329-4040
OpenAlex ID:
A5018582488
The Next Frontier: Translational Development of Ubiquitination, SUMOylation, and NEDDylation in Cancer
2022
·
Nicole E. Pellegrino
, Arcan Guven
, et al.
·
International Journal of Molecular Sciences
·
59
PDF
‘Real-life experience’: recurrence rate at 3 years with Hexvix® photodynamic diagnosis-assisted TURBT compared with good quality white light TURBT in new NMIBC—a prospective controlled study
2017
·
Kevin M. Gallagher
, Kayleigh Gray
, et al.
·
World Journal of Urology
·
45
PDF
Multiplexed LC-MS/MS analysis of methylsuccinic acid, ethylmalonic acid, and glutaric acid in plasma and urine
2022
·
Kuan-Wei Peng
, Allison Klotz
, et al.
·
Analytical Biochemistry
·
4
Development and validation of an immunoassay for quantification of NCAM-1 in human plasma
2021
·
Arcan Guven
, Kayleigh Gray
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
3
Abstract 1663: Development of a novel oral microtubule targeting agent with pan-cancer efficacy
2023
·
Maria-Dorothea Nastke
, Jacob Matson
, et al.
·
Cancer Research
·
1
Abstract 5320: BRG399, a small molecule modulator of UBE2K demonstrated dose-dependent anti-cancer efficacy in an in vivo model for gastric cancer
2022
·
Shiva Kazerounian
, Mollie O'Hara
, et al.
·
Cancer Research
·
1
Abstract 2943: Interrogative Biology® platform identifies a novel target in the ubiquitin pathway and its utility in cancer is supported by small molecule modulators
2020
·
Stephane Gesta
, Shefali Sharma
, et al.
·
Cancer Research
Show more works
View as search
Works count:
7
Citation count:
113
H-index:
3
I10-index:
2
Year
Topic
Type
